tolak
Generic: fluorouracil
Labeler: hill dermaceuticals, inc.Drug Facts
Product Profile
Brand Name
tolak
Generic Name
fluorouracil
Labeler
hill dermaceuticals, inc.
Dosage Form
CREAM
Routes
Active Ingredients
fluorouracil .04 g/g
Manufacturer
Identifiers & Regulatory
Product NDC
28105-421
Product ID
28105-421_db3a1489-fcb1-4442-b309-4eb8ad9b9f46
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022259
Listing Expiration
2026-12-31
Marketing Start
2015-09-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
28105421
Hyphenated Format
28105-421
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tolak (source: ndc)
Generic Name
fluorouracil (source: ndc)
Application Number
NDA022259 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .04 g/g
Packaging
- 1 TUBE in 1 CARTON (28105-421-40) / 40 g in 1 TUBE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "db3a1489-fcb1-4442-b309-4eb8ad9b9f46", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["U3P01618RT"], "rxcui": ["1669868", "1669873"], "spl_set_id": ["59de2709-00b8-4f0a-867c-f0dfeb947192"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["HILL DERMACEUTICALS, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (28105-421-40) / 40 g in 1 TUBE", "package_ndc": "28105-421-40", "marketing_start_date": "20150918"}], "brand_name": "TOLAK", "product_id": "28105-421_db3a1489-fcb1-4442-b309-4eb8ad9b9f46", "dosage_form": "CREAM", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "28105-421", "generic_name": "FLUOROURACIL", "labeler_name": "HILL DERMACEUTICALS, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOLAK", "active_ingredients": [{"name": "FLUOROURACIL", "strength": ".04 g/g"}], "application_number": "NDA022259", "marketing_category": "NDA", "marketing_start_date": "20150918", "listing_expiration_date": "20261231"}